EUVIMEDEUVIMED entdecken
Multizentrische Studie

Transapical transcatheter mitral valve replacement for mitral valve disease: an Iberian experience

Eva Gutiérrez-Ortiz, Javier Cobiella, Christian Muñoz-Guijosa, Rui C Teles, Rodrigo Estévez-Loureiro, Vanessa Moñivas, Ander Regueiro, Sara Blasco-Turrión, Patricia Mahía, Danela Figuereo Beltre, Pedro Freitas, Miguel Piñón und 6 weitere

Revista Española de Cardiología (English Edition) · 2025-03 · 78 (3) · 229-238

DOI: 10.1016/j.rec.2024.07.004 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025-03. Verfasst von Eva Gutiérrez-Ortiz und 17 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Cirugía Cardiaca, Instituto Cardiovascular, Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IdISSC), Hospital …. Hauptthemen laut MEDLINE: Heart Valve Prosthesis Implantation, Mitral Valve, Cardiac Catheterization, Mitral Valve Insufficiency. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Transcatheter mitral valve replacement (TMVR) is an emerging treatment alternative for mitral valve (MV) disease in patients who were ineligible for surgical intervention or edge-to-edge repair. This study aimed to assess the short- and mid-term outcomes of this procedure. METHODS: We conducted a prospective registry to include the initial experience with symptomatic, consecutive patients who underwent TMVR using the transapical Tendyne system at 7 centers in the Iberian Peninsula. Baseline clinical and imaging data, periprocedural information, and follow-up assessments were collected at 1 month and 1 year. RESULTS: A total of 40 patients (mean age 78.5 years [76-82], 47,5% males) underwent TMVR. The majority had significant surgical risk, comorbidities, and advanced functional class. All patients had significant mitral regurgitation (MR), except for 2 with severe stenosis. Previous MV intervention and off-label indication for the procedure were present in 4 (10.0%) and 8 (20.0%) patients, respectively. Technical success was recorded in 100%, device success in 95.0%, and procedural success in 85.0% at 30-day. All-cause mortality was 2.5% and 17.5% at the 1-month and 1-year follow-up, respectively. MR reduction (≤ 1) and functional class improvement (NYHA I-II) were observed at 1 year in 93.9% and 87.9% of survivors, respectively. CONCLUSIONS: Treatment with TMVR produced enduring resolution of MV disease and notable functional enhancement at 1 year of follow-up. The procedure demonstrated a satisfactory early safety profile, although 1-year mortality remained relatively high in this high-risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Valve Prosthesis ImplantationMitral ValveCardiac CatheterizationMitral Valve InsufficiencyRegistriesHumansMaleFemaleAgedAged, 80 and overProspective StudiesSpainTreatment OutcomeFollow-Up StudiesHeart Valve Prosthesis

Stichwörter der Autor:innen

Enfermedad de la válvula mitralInsuficiencia mitralMitral regurgitationMitral valve diseaseReemplazo percutáneo de la válvula mitralSistema TendyneTendyne systemTranscatheter mitral valve implantationTranscatheter mitral valve replacement

Autor:innen und Institutionen

  • Servicio de Cirugía Cardiaca, Instituto Cardiovascular, Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IdISSC), Hospital Clínico San Carlos, Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain; Servicio de Cardiología, Hospital Universitario Germans Trias I Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona,…
  • Department of Cardiology, Hospital de Santa Cruz, Lisboa, Portugal.
  • Departamento de Cirugía Cardiaca, Hospital Universitario Álvaro Cunqueiro, Instituto de Investigación en Salud Galicia Sur, Vigo, Pontevedra, Spain.
  • Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.
  • Servicio de Cardiología, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Barcelona, Spain.

Zitieren

APA

Gutiérrez-Ortiz, E., Cobiella, J., Muñoz-Guijosa, C., Teles, R. C., Estévez-Loureiro, R., Moñivas, V., Regueiro, A., Blasco-Turrión, S., Mahía, P., Figuereo Beltre, D., Freitas, P., Piñón, M., Amat-Santos, I. J., Julià Amill, I., Nolasco, T., Pereda, D., Martín López, C., & Nombela-Franco, L. (2025). Transapical transcatheter mitral valve replacement for mitral valve disease: an Iberian experience. Revista Española de Cardiología (English Edition), 78(3), 229-238. https://doi.org/10.1016/j.rec.2024.07.004

Vancouver

Gutiérrez-Ortiz E, Cobiella J, Muñoz-Guijosa C, Teles RC, Estévez-Loureiro R, Moñivas V, et al. Transapical transcatheter mitral valve replacement for mitral valve disease: an Iberian experience. Revista Española de Cardiología (English Edition). 2025;78(3):229-238. doi:10.1016/j.rec.2024.07.004

BibTeX
@article{GutirrezOrtiz2025,
  author = {Gutiérrez-Ortiz, Eva and Cobiella, Javier and Muñoz-Guijosa, Christian and Teles, Rui C and Estévez-Loureiro, Rodrigo and Moñivas, Vanessa and Regueiro, Ander and Blasco-Turrión, Sara and Mahía, Patricia and Figuereo Beltre, Danela and Freitas, Pedro and Piñón, Miguel and Amat-Santos, Ignacio J and Julià Amill, Ignasi and Nolasco, Tiago and Pereda, Daniel and Martín López, Carlos and Nombela-Franco, Luis},
  title = {Transapical transcatheter mitral valve replacement for mitral valve disease: an Iberian experience},
  journal = {Revista Española de Cardiología (English Edition)},
  year = {2025},
  volume = {78},
  number = {3},
  pages = {229--238},
  doi = {10.1016/j.rec.2024.07.004}
}
Kostenlos starten →